| Literature DB >> 29023536 |
Sandra Haider1, Igor Grabovac1, Eva Winzer1, Ali Kapan1, Karin Emmi Schindler2, Christian Lackinger3, Sylvia Titze4, Thomas Ernst Dorner1.
Abstract
The aim of the study was to compare the effects of home visits with physical training and nutritional support on inflammatory parameters to home visits with social support alone within a randomized controlled trial. Prefrail and frail persons received home visits from lay volunteers twice a week for 12 weeks. Participants in the physical training and nutritional intervention group (PTN, n = 35) conducted two sets of six strength exercises and received nutritional support. The social support group (SoSu, n = 23) received visits only. TNF-α, IL-6, CRP, and total leukocyte count were assessed at baseline and after 12 weeks. Changes over time within groups were analyzed with paired t-tests; differences between groups were analyzed with ANCOVA for repeated measurements. In the PTN group, IL-6 and CRP remained stable, whereas in the SoSu group, IL-6 increased significantly from a median value of 2.6 pg/l (min-max = 2.0-10.2) to 3.0 pg/l (min-max = 2.0-20.8), and CRP rose from 0.2 mg/dl (min-max = 0.1-0.9) to 0.3 mg/dl (min-max = 0.1-3.0) after 12 weeks. In CRP, a significant difference between groups was found. TNF-α and total leukocyte count did not change in either the PTN group or the SoSu group. Persons showing an increase in physical performance (OR 4.54; 95% CI = 1.33-15.45) were more likely to have constant or decreased IL-6 values than persons who showed no improvement. In conclusion, in non-robust older adults, a physical training and nutritional support program provided by lay volunteers can delay a further increase in some inflammatory parameters.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29023536 PMCID: PMC5638289 DOI: 10.1371/journal.pone.0185879
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Participant flow.
Baseline characteristics of the study sample.
| Physical training and nutritional | Social | p-value | |
|---|---|---|---|
| n = 35 | n = 23 | ||
| Female, n (%) | 30 (85.7) | 19 (82.6) | 0.876 |
| Age (years) | 83.1 (7.8) | 81.4 (8.7) | 0.433 |
| Frailty status (SHARE-FI score) | 2.8 (1.1) | 2.9 (0.9) | 0.664 |
| Nutritional status (MNA®-SF score) | 11.2 (2.5) | 10.5 (2.5) | 0.281 |
| Body mass index (kg/m2) | 27.5 (5.0) | 27.0 (3.0) | 0.608 |
| Fat mass index (kg/m2) | 10.5 (3.5) | 10.6 (2.4) | 0.936 |
| Appendicular skeletal muscle mass index (kg/m2) | 6.8 (1.2) | 6.3 (0.8) | 0.081 |
| Phase angle (°) | 4.0 (0.6) | 4.0 (0.7) | 0.957 |
| Handgrip strength (kg/m2) | 17.6 (7.4) | 16.8 (6.80) | 0.687 |
| Physical performance (SPPB score) | 5.2 (2.7) | 4.3 (3.0) | 0.229 |
| Tumor necrosis factor alpha (pg/ml) | 10.2 (3.4) | 10.1 (2.7) | 0.825 |
| Interleukin-6 (pg/ml) | 2.6 (2.0–17.2) | 2.6 (2.0–30.6) | 0.951 |
| C-reactive protein (mg/dl) | 0.2 (0.1–1.7) | 0.2 (0.1–5.6) | 0.639 |
| Leukocytes total (g/l) | 7.0 (2.0) | 6.9 (1.7) | 0.904 |
| Arthritis, n (%) | 8 (22.9) | 2 (8.7) | 0.287 |
| Chronic rheumatism, n (%) | 4 (11.4) | 2 (8.7) | 1.000 |
| Cancer, n (%) | 3 (8.6) | 3 (13.0) | 1.000 |
| Hypertension, n (%) | 28 (80.0) | 15 (65.2) | 0.796 |
| Myocardial infarction, n (%) | 3 (8.6) | 1 (4.3) | 1.000 |
| Heart insufficiency, n (%) | 9 (25.7) | 5 (21.7) | 1.000 |
| Stroke, n (%) | 6 (17.1) | 1 (4.3) | 0.226 |
| Diabetes mellitus type 2, n (%) | 4 (11.4) | 5 (21.7) | 0.460 |
| Charlson comorbidity (index) | 5.2 (1.5) | 5.3 (1.5) | 0.618 |
| Numbers of different drugs per day | 8 (0–16) | 8 (0–19) | 0782 |
| Anti-inflammatory medication, n (%) | 11 (31.4) | 5 (21.7) | 0.419 |
Continuous data are presented as mean (standard deviation) or median (minimum–maximum), categorical variables as frequencies (percentages). SHARE-FI = Frailty Instrument of the Survey of Health, Ageing and Retirement in Europe; MNA®-SF = Mini Nutritional Assessment Short-Form; SPPB = Short Physical Performance Battery.
a Values are based on t-tests or Mann-Whitney U-tests (continuous variables) and Fisher’s exact test (categorical variables).
b Including medications with the following chemical agents: ciclesonide, dexibuprofen, diclofenac, fluticasone-propionate, ibuprofen, lornoxicam, mefenamic acid, meloxicam, naproxen, and prednisone.
Changes in inflammatory parameters from baseline to 12 weeks.
| Differences | Differences | |||
|---|---|---|---|---|
| Mean change (95% CI) | p-value | p-value | ||
| TNF-α (pg/ml) | PTN | −0.32 (−1.24–0.38) | 0.287 | 0.469 |
| SoSu | −0.47 (−1.40–0.46) | 0.303 | ||
| Log-IL-6 (pg/ml) | PTN | 0.11 (−0.11–0.33) | 0.304 | 0.343 |
| SoSu | 0.19 (0.00–0.37) | 0.047 | ||
| Log-CRP (mg/dl) | PTN | 0.08 (−0.16–0.32) | 0.501 | 0.040 |
| SoSu | 0.46 (0.07–0.85) | 0.022 | ||
| Leukocytes total (g/l) | PTN | 0.48 (−0.04–1.01) | 0.070 | 0.839 |
| SoSu | 0.46 (−0.22–1.13) | 0.177 | ||
PTN = physical training and nutritional intervention group (n = 35); SoSu = social support group (n = 23).
a Differences over time were calculated using paired t-tests. Mean change and 95% confidence interval (95% CI) are presented.
b Differences between groups were calculated using analysis of covariance (ANCOVA) for repeated measurements, adjusted for baseline value, sex, age, anti-inflammatory medication, and chronic rheumatism.
Association between baseline values of inflammatory parameters and baseline values of body composition parameters, handgrip strength, and physical performance.
| TNF-α | Log-IL-6 | Log-CRP | Leukocytes total | |||||
|---|---|---|---|---|---|---|---|---|
| ß | 0070 | ß | p-value | ß | p-value | ß | p-value | |
| Frailty status (SHARE-FI) | 0.183 | 0.117 | 0.021 | 0.889 | −0.056 | 0.645 | ||
| Body mass index (kg/m2) | 0.173 | 0.207 | 0.140 | 0.302 | 0.228 | 0.105 | 0.188 | 0.171 |
| Fat mass index (kg/m2) | 0.241 | 0.117 | 0.142 | 0.353 | 0.234 | 0.137 | 0.243 | 0.115 |
| ASMMI (kg/m2) | 0.127 | 0.357 | 0.084 | 0.536 | 0.218 | 0.123 | 0.075 | 0.589 |
| Phase angle (°) | −0.188 | 0.137 | −0.242 | 0.052 | 0.169 | 0.198 | 0.038 | 0.766 |
| Handgrip strength (kg/m2) | −0.149 | 0.233 | 0.043 | 0.748 | −0.043 | 0.732 | ||
| Physical performance (SPPB) | −0.239 | 0.051 | 0.085 | 0.480 | 0.177 | 0.151 | ||
In these analyses, patients who were lost to follow-up were also included (n = 73). Values are based on univariate linear regression analyses, with inflammatory parameters as the dependent variables, adjusted for sex, age, anti-inflammatory medication, and chronic rheumatism. Standardized ß-values are reported.
*As the CRP values become negative numbers after log-transformation, associations appearing as positive must be interpreted as negative associations.
ASMMI = appendicular skeletal muscle mass index; SPPB = Short Physical Performance Battery; SHARE-FI = Frailty Instrument of the Survey of Health, Ageing and Retirement in Europe.
Association between constant or decreased (versus increased) inflammatory parameters within 12 weeks and baseline values/changes in frailty score, handgrip strength, and physical performance.
| Constant or decreased | ||||||||
|---|---|---|---|---|---|---|---|---|
| TNF-α | Log-IL-6 | Log-CRP | Leukocytes total | |||||
| OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | |
| BL frailty status (SHARE-FI score) | 0.79 (0.43–1.46) | 0.447 | 1.18 (0.66–2.09) | 0.570 | 0.62 (0.30–1.27) | 0.194 | 1.14 (0.65–2.01) | 0.642 |
| BL handgrip strength (kg/m2) | 0.94 (0.83–1.05) | 0.265 | 0.99 (0.89–1.09) | 0.801 | 1.00 (0.88–1.14) | 0.978 | 0.97 (0.88–1.08) | 0.591 |
| BL physical performance (SPPB score) | 1.09 (0.85–1.39) | 0.495 | 0.96 (0.77–1.20) | 0.720 | 1.16 (0.90–1.51) | 0.262 | 0.97 (0.78–1.21) | 0.798 |
| Constant or decreased | 1.75 (0.45–6.79) | 0.418 | 1.30 (0.40–4.29) | 0.663 | 2.47 (0.56–10.93) | 0.233 | 0.95 (0.29–3.11) | 0.929 |
| Increased | 1 | 1 | 1 | 1 | ||||
| Constant or decreased | 1 | 1 | 1 | 1 | ||||
| Increased | 0.52 (0.15–1.84) | 0.307 | 1.29 (0.42–3.93) | 0.658 | 0.66 (0.17–2.51) | 0.541 | 0.63 (0.21–1.93) | 0.421 |
| Constant or decreased | 1 | 1 | 1 | 1 | ||||
| Increased | 0.56 (0.16–2.03) | 0.378 | 0.49 (0.13–1.87) | 0.294 | ||||
Values are based on univariate logistic regression analyses, with constant or decreased inflammatory parameters (≤0.00 units) as dependent variables, adjusted for sex, age, anti-inflammatory medication, chronic rheumatism, and group. Odds ratio (OR) and 95% confidence interval (95% CI) are presented. BL = baseline; SHARE-FI = Frailty Instrument of the Survey of Health, Ageing and Retirement in Europe; SPPB = Short Physical Performance Battery, Δ = changes from baseline to 12 weeks.